Drug Discovery
Exploring knowledge graphs for COVID-19 drug discovery
The methodology behind CAS knowledge graphs enhances potential drug identification for COVID-19 treatment and other diseases.
Read the CAS Insights article
Bio
As a Senior Scientific Content Engineer at CAS, Jacob Al-Saleem develops bioinformatic solutions using machine learning, deep learning, and natural language programming to extract and connect scientific knowledge from text. Prior to joining CAS, he earned his B.S. in Molecular Genetics and Ph.D. in Molecular Cellular and Developmental Biology from The Ohio State University. His Ph.D. studies were focused on the molecular virology of Human T cell Leukemia Viruses (HTLV).